Core Viewpoint - The financial performance of Kangtong Medical in the first half of 2025 shows significant declines in revenue and net profit, indicating potential challenges for the company moving forward [1][2]. Financial Performance - The company's revenue for the first half of 2025 was 265 million yuan, a year-on-year decrease of 39.29% [1]. - The net profit attributable to shareholders was -8.4044 million yuan, a year-on-year decline of 154.53% [1]. - The basic earnings per share were -0.09 yuan [1]. - The gross profit margin for the first half of 2025 was 22.09%, an increase of 3.65 percentage points year-on-year [2]. - The net profit margin was -3.45%, a decrease of 6.97 percentage points compared to the same period last year [2]. Cost Structure - Total operating expenses for the first half of 2025 were 48.8419 million yuan, a decrease of 2.3451 million yuan year-on-year [2]. - The expense ratio was 18.41%, an increase of 6.70 percentage points year-on-year [2]. - Sales expenses decreased by 24.03%, while management expenses increased by 12.24% [2]. Shareholder Information - As of the end of the first half of 2025, the total number of shareholders was 8,154, a decrease of 301 from the previous quarter, representing a decline of 3.56% [3]. - The average market value per shareholder increased from 220,200 yuan to 249,300 yuan, an increase of 13.21% [3]. Business Overview - Kangtong Medical, established on January 13, 1998, is located in Chengdu, Sichuan Province, and was listed on July 25, 2023 [3]. - The company's main business involves providing medical institutions with overall solutions centered on medical gas systems and clean surgical departments [3]. - The revenue composition includes: 55.69% from clean medical equipment and systems, 37.30% from medical gas equipment and systems, 4.06% from medical devices and other product sales, 2.81% from operation and maintenance services, and 0.14% from other sources [3].
港通医疗上半年营收2.65亿元同比降39.29%，归母净利润-840.44万元同比降154.53%，净利率下降6.97个百分点